These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 20483717

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.
    Buchert R, Thomasius R, Wilke F, Petersen K, Nebeling B, Obrocki J, Schulze O, Schmidt U, Clausen M.
    Am J Psychiatry; 2004 Jul; 161(7):1181-9. PubMed ID: 15229049
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB.
    McCann UD, Szabo Z, Seckin E, Rosenblatt P, Mathews WB, Ravert HT, Dannals RF, Ricaurte GA.
    Neuropsychopharmacology; 2005 Sep; 30(9):1741-50. PubMed ID: 15841106
    [Abstract] [Full Text] [Related]

  • 13. Reversibility of ecstasy-induced reduction in serotonin transporter availability in polydrug ecstasy users.
    Buchert R, Thomasius R, Petersen K, Wilke F, Obrocki J, Nebeling B, Wartberg L, Zapletalova P, Clausen M.
    Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):188-99. PubMed ID: 16133393
    [Abstract] [Full Text] [Related]

  • 14. Long-term effects of "ecstasy" use on serotonin transporters of the brain investigated by PET.
    Buchert R, Thomasius R, Nebeling B, Petersen K, Obrocki J, Jenicke L, Wilke F, Wartberg L, Zapletalova P, Clausen M.
    J Nucl Med; 2003 Mar; 44(3):375-84. PubMed ID: 12621003
    [Abstract] [Full Text] [Related]

  • 15. Are ecstasy induced serotonergic alterations overestimated for the majority of users?
    Szigeti B, Winstock AR, Erritzoe D, Maier LJ.
    J Psychopharmacol; 2018 Jul; 32(7):741-748. PubMed ID: 29733742
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Serotonergic neurotransmission in emotional processing: New evidence from long-term recreational poly-drug ecstasy use.
    Laursen HR, Henningsson S, Macoveanu J, Jernigan TL, Siebner HR, Holst KK, Skimminge A, Knudsen GM, Ramsoy TZ, Erritzoe D.
    J Psychopharmacol; 2016 Dec; 30(12):1296-1304. PubMed ID: 27599522
    [Abstract] [Full Text] [Related]

  • 18. Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET.
    Buchert R, Obrocki J, Thomasius R, Väterlein O, Petersen K, Jenicke L, Bohuslavizki KH, Clausen M.
    Nucl Med Commun; 2001 Aug; 22(8):889-97. PubMed ID: 11473208
    [Abstract] [Full Text] [Related]

  • 19. Neuroimaging research in human MDMA users: a review.
    Cowan RL.
    Psychopharmacology (Berl); 2007 Jan; 189(4):539-56. PubMed ID: 16847678
    [Abstract] [Full Text] [Related]

  • 20. Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects.
    Reneman L, de Win MM, van den Brink W, Booij J, den Heeten GJ.
    J Psychopharmacol; 2006 Mar; 20(2):164-75. PubMed ID: 16510475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.